07 Jan 2001

Doxymono® 100 (Doxymono® 100/-200 Tabletten) - Deutschland

Updated: 07 Jan 2001

Doxymono® 100 | -200

Infektionen, verursacht durch Doxycyclin-empfindl. Krankheitserreger, z. B. d. Atemwege u. d. HNO-Bereiches, akute Schübe chron. Bronchitis, Sinusitis, Otitis media, Pneumonie durch Mykoplasmen, Rickettsien od. Chlamydien. Infekt. d. Urogenitaltraktes, Urethritis durch Chlamydien u. Ureaplasma urealyticum, akute Prostatitis, unkomplizierte Gonorrhoe (insb. b. gleichz. Chlamydieninf.). Infekt. d. weibl. Geschlechtsorgane, Syphilis b. Penicillin-Allergie, Harnwegsinfekt. (nur b. nachgewiesener Empf. d. Erregers). Infekt. d. Magen-Darm-Traktes, Cholera, Yersinien- od. Campylobacter-Infekt. Shigellen-Inf. b. Nachweis d. Empf. Malabsorptionssyndrome wie tropische Sprue u. Morbus Whipple. Ambulante Ther. v. Gallenwegsinfekt. Hauterkr. auch infizierte schwere Formen d. Akne vulg. u. Rosacea, Chlamydien-Konjunktivitis u. Trachom, Borreliosen wie Erythema chronicum migrans u. Lyme-Disease, seltene Infektionen, wie Bartonellose, Brucellose, Listeriose, Ornithose, Rickettsiose, Melioidose, Pest, Granuloma inguinale

Doxymono® 100 Description, Presentation and Dosage

Doxymono® 100 Description

Doxymono® 100 Drug Class Description

Doxycyclin

Doxymono® 100 Drug Description

1 teilbare Tbl. enth.: Doxycyclin 1H2O 104,1 mg/208,2 mg (entspr. 100 mg/200 mg Doxycyclin).

Doxymono® 100 Generic Name

Doxymono® 100/-200 Tabletten

Doxymono® 100 Presentation

Doxymono® 100 Presentation

Doxymono® 100/-200

Doxymono® 100 Manufacturer

betapharm

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Doxymono® 100 Dosage

Doxymono® 100 Adult Dosage

mikrokristalline Cellulose, Magnesiumstearat, Poly(O-carboxymethyl)stärke-Natriumsalz, Povidon, hydriertes Rizinusöl, hochdisp. Siliciumdioxid.

Doxymono® 100 Precautions, Reactions and Contraindications

Doxymono® 100 Special Precautions

Doxymono® 100 Special Precautions

T 15 a, b

Doxymono® 100 Adverse Reactions

Doxymono® 100 Adverse Reactions

T 15

Related Drugs - Infectious Diseases

Back to top